Hims & Hers Q1 earnings miss sends shares lower; see revenue, margins, subscriber growth and raised guidance tied to Novo ...
Quarterly filings reveal markedly different revenue trajectories and margin profiles for these two healthcare platforms. What ...
Hims & Hers Health, Inc. remains a Buy, with a solid bottom forming despite recent margin and revenue challenges. Read more ...
Shares of Hims & Hers Health (NYSE:HIMS) are under pressure after JPMorgan trimmed its price target on the consumer ...
In today's Asking Eric column, R. Eric Thomas responds to someone who does not get along with their sister, who has become ...
“Total Eclipse of the Heart” singer Bonnie Tyler experienced a recent health scare and had to undergo emergency surgery in ...
Atlanta Black Star on MSN
‘Seriously … What Happened?’: Demi Moore’s Cannes Look Backfires as Fans Get Distracted by One Disturbing Detail That Fuels Major Health Concerns
Actress Demi Moore has built an image around her timeless beauty, glowing skin, and her signature long black hair, often ...
Angelina Jolie has sparked fresh panic over her health, with insiders blaming ex Brad Pitt and their bitter, years-long legal ...
Dolly Parton's latest health reassurance has done little to calm growing fears around the country icon, with skeptics branding her upbeat public updates a "smokescreen" masking deeper concerns about ...
StockStory.org on MSN
Hims & Hers Health (NYSE:HIMS) misses Q1 CY2026 sales expectations, stock drops 11.5%
Telehealth company Hims & Hers Health (NYSE:HIMS) in Q1 CY2026 as sales rose 3.8% year on year to $608.1 million. On the ...
“She has not been able to get approved for a mortgage, so I want to help her.” ...
The country icon says her meds are preventing her from performing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results